| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044267436 |
| P356 | DOI | 10.1007/S002800000160 |
| P8608 | Fatcat ID | release_dxvnext5gna7poxjo2kdkjtw2y |
| P698 | PubMed publication ID | 11052628 |
| P2093 | author name string | Riva A | |
| Bombardelli E | |||
| Distefano M | |||
| Mancuso S | |||
| Scambia G | |||
| Morazzoni P | |||
| Valenti P | |||
| Ferlini C | |||
| Ranelletti FO | |||
| Gaggini C | |||
| De Vincenzo R | |||
| Belluti F | |||
| P433 | issue | 4 | |
| P304 | page(s) | 305-312 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | In vitro evaluation of newly developed chalcone analogues in human cancer cells | |
| P478 | volume | 46 |
| Q34302390 | (E)-3-(4-Fluoro-phen-yl)-1-(2-nitro-phen-yl)prop-2-en-1-one. |
| Q35616297 | (E)-3-(Furan-2-yl)-1-(4-meth-oxy-phen-yl)prop-2-en-1-one |
| Q34269774 | 1-(4-Chloro-phen-yl)-3-(5-methyl-2-fur-yl)prop-2-en-1-one |
| Q41951709 | 3-(2-Fluoro-phen-yl)-1-(4-methoxy-phen-yl)prop-2-en-1-one |
| Q34265154 | 3-(4-Fluoro-phen-yl)-1-(4-methoxy-phen-yl)prop-2-en-1-one |
| Q34272688 | 3-(4-Methoxy-phen-yl)-1-(2-nitrophen-yl)prop-2-en-1-one |
| Q42406597 | 3-(5-Methyl-2-fur-yl)-1-(p-tol-yl)-2-propen-1-one |
| Q46952415 | Antioxidant activity of plicatin B on cultured human microvascular endothelial cells exposed to H2O2. |
| Q44247228 | Cytotoxic and inhibitory effects of 4,4'-dihydroxy chalcone (RVC-588) on proliferation of human leukemic HL-60 cells. |
| Q54421689 | Effects of licochalcone A on the bioavailability and pharmacokinetics of nifedipine in rats: possible role of intestinal CYP3A4 and P-gp inhibition by licochalcone A. |
| Q42320319 | Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids |
| Q45917029 | Evaluation of silica-H2SO4 as an efficient heterogeneous catalyst for the synthesis of chalcones. |
| Q35533265 | Flavonoids: A versatile source of anticancer drugs |
| Q35112798 | Flavonoids: Promising anticancer agents |
| Q27021479 | Molecular targeted approaches to cancer therapy and prevention using chalcones |
| Q36022800 | Naturally Inspired Molecules as Multifunctional Agents for Alzheimer's Disease Treatment. |
| Q41990704 | New eco-friendly animal bone meal catalysts for preparation of chalcones and aza-Michael adducts |
| Q34811676 | Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance. |
| Q38174655 | Site-specific anticancer effects of dietary flavonoid quercetin |
| Q41842488 | Structural antitumoral activity relationships of synthetic chalcones |
| Q39062146 | Synthetic chalcone derivatives as inhibitors of cathepsins K and B, and their cytotoxic evaluation |
| Q35083696 | The effect of food components on the absorption of P-gp substrates: a review. |
| Q40127650 | Trans-4-lodo,4'-boranyl-chalcone induces antitumor activity against malignant glioma cell lines in vitro and in vivo |
Search more.